Skip to content

max iv

Mining the secrets of lipid nanoparticles using research infrastructures

Hanna Barriga has over 10 years of experience engineering and characterizing lipid systems. Her research focuses on understanding how lipid structures impact nanoparticle performance, which includes developing lipid nanoparticles for RNA delivery. We got the opportunity to talk to Hanna to learn how she uses research infrastructure to take her research towards the applied biology of drug targeting. 

Antibiotic research pushed forward by use of large infrastructures

Robert Schnell is a scientist at Karolinska Institute focusing on development of novel antibiotic candidates. He has used both SciLifeLab and MAX IV laboratory infrastructures in a multifaceted project addressing the problem of infectious diseases in the context of the silent pandemic of antimicrobial resistance (AMR).